STMN1 promotes cell malignancy and bortezomib resistance of multiple myeloma cell lines via PI3K/AKT signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

STMN1 promotes cell malignancy and bortezomib resistance of multiple myeloma cell lines via PI3K/AKT signaling

Published:2023-08-29 Issue: Volume: Page:1-10
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Wang Ling¹,Cao Jie²,Tao Jian¹,Liang Yan³

Affiliation:

1. Department of Hematology, The Second Affiliated Hospital of Nantong University, Nantong, China

2. Department of Pathology, The Second Affiliated Hospital of Nantong University, Nantong, China

3. Department of Oncology, The First Affiliated Hospital of Nanjing Medicine University, Nanjing, China

Funder

Youth project of Nantong Municipal Health Commission

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2251384

Reference34 articles.

1. Quality of Life and Supportive Care in Multiple Myeloma

2. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

3. Incidence and mortality of multiple myeloma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016

4. Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989

5. Improved survival in multiple myeloma and the impact of novel therapies

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular cloning, tissue expression, and bioinformatics analysis of STMN1 gene from Anhui White Goats;Gene Reports;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3